Elective neck dissection in oral squamous cell carcinoma: Past, present and future.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
03 2019
Historique:
received: 10 07 2018
revised: 01 01 2019
accepted: 25 01 2019
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 9 4 2020
Statut: ppublish

Résumé

In 1994 a decision analysis, based on the literature and utility ratings for outcome by a panel of experienced head and neck physicians, was presented which showed a threshold probability of occult metastases of 20% to recommend elective treatment of the neck. It was stated that recommendations for the management of the cN0 neck are not immutable and should be reconfigured to determine the optimal management based on different sets of underlying assumptions. Although much has changed and is published in the almost 25 years after its publication, up to date this figure is still mentioned in the context of decisions on treatment of the clinically negative (cN0) neck. Therefore, we critically reviewed the developments in diagnostics and therapy and modeling approaches in the context of decisions on treatment of the cN0 neck. However, the results of studies on treatment of the cN0 neck cannot be translated to other settings due to significant differences in relevant variables such as population, culture, diagnostic work-up, follow-up, costs, institutional preferences and other factors. Moreover, patients may have personal preferences and may weigh oncologic outcomes versus morbidity and quality of life differently. Therefore, instead of trying to establish "the" best strategy for the cN0 neck or "the" optimal cut-off point for elective neck treatment, the approach to optimize the management of the cN0 neck would be to develop and implement models and decision support systems that can serve to optimize choices depending on individual, institutional, population and other relevant variables.

Identifiants

pubmed: 30846183
pii: S1368-8375(19)30027-2
doi: 10.1016/j.oraloncology.2019.01.016
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-93

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Remco de Bree (R)

Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: r.debree@umcutrecht.nl.

Robert P Takes (RP)

Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Jatin P Shah (JP)

Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marc Hamoir (M)

Department of Head and Neck Surgery, Head and Neck Oncology Program, St Luc University Hospital and Cancer Center, Brussels, Belgium.

Luiz P Kowalski (LP)

Department Otorhinolaryngology-Head and Neck Surgery, Centro de Tratamento e Pesquisa Hospital do Cancer A.C. Camargo, São Paulo, Brazil.

K Thomas Robbins (KT)

Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, USA.

Juan P Rodrigo (JP)

Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, Oviedo, Spain; Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.

Alvaro Sanabria (A)

Department of Surgery, School of Medicine, Universidad de Antioquia, Clínica Vida/Instituto de Cancerología Las Américas, Medellín, Colombia.

Jesus E Medina (JE)

Department of Otorhinolaryngology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Alessandra Rinaldo (A)

University of Udine School of Medicine, Udine, Italy.

Ashok R Shaha (AR)

Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Carl Silver (C)

Department of Surgery, University of Arizona College of Medicine, Phoenix, AZ, USA.

Carlos Suárez (C)

Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain; Fundación de Investigación e Innovación Biosanitaria del Principado de Asturias, Oviedo, Spain.

Manuel Bernal-Sprekelsen (M)

Department of Otorhinolaryngology, Hospital Clinic, University of Barcelona Medical School, Barcelona, Spain.

Alfio Ferlito (A)

Coordinator of the International Head and Neck Scientific Group, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH